Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Holley
HLLY
$362M
| $993K | ﹤0.01% |
+94,600
| New | +$1.03M |
|
2727
Scholastic
SCHL
$784M
| $993K | ﹤0.01% |
27,600
+17,500
| +173% | +$646K |
|
2728
Xeris Biopharma Holdings
XERS
$1.55B
| $991K | ﹤0.01% |
643,694
-49,300
| -7% | -$104K |
|
2729
Bio-Rad Laboratories Class B
BIO.B
| $990K | ﹤0.01% |
2,100
+100
| +5% | +$53.4K |
|
2730
Federated Hermes
FHI
$4.7B
| $989K | ﹤0.01% |
+31,100
| New | +$985K |
|
|
CMPS
2731
Compass Pathways
CMPS
$1.84B
| $988K | ﹤0.01% |
91,300
-37,900
| -29% | -$383K |
|
2732
Ranger Energy Services
RNGR
$405M
| $987K | ﹤0.01% |
97,297
-26,493
| -21% | -$267K |
|
2733
CEL-SCI Corp
CVM
$25.9M
| $985K | ﹤0.01% |
7,296
-18,467
| -72% | -$1.92M |
|
|
LOAN
2734
Manhattan Bridge Capital
LOAN
$47.2M
| $985K | ﹤0.01% |
175,841
+3,623
| +2% | +$20.4K |
|
|
OGI
2735
Organigram Holdings
OGI
$177M
| $984K | ﹤0.01% |
268,238
+210,238
| +362% | +$1.07M |
|
2736
CuriosityStream
CURI
$237M
| $983K | ﹤0.01% |
581,500
+403,330
| +226% | +$814K |
|
|
ETNB
2737
DELISTED
89bio
ETNB
| $982K | ﹤0.01% |
304,867
+41,467
| +16% | +$125K |
|
|
PSTX
2738
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $981K | ﹤0.01% |
380,100
+193,100
| +103% | +$537K |
|
2739
Lifetime Brands
LCUT
$219M
| $976K | ﹤0.01% |
88,406
+8,906
| +11% | +$105K |
|
|
CBD
2740
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $972K | ﹤0.01% |
313,700
-411,800
| -57% | -$1.75M |
|
|
LUNA
2741
DELISTED
Luna Innovations Incorporated
LUNA
| $971K | ﹤0.01% |
166,501
+21,600
| +15% | +$127K |
|
2742
Kaltura
KLTR
$241M
| $967K | ﹤0.01% |
485,811
-65,489
| -12% | -$112K |
|
2743
UTStarcom
UTSI
$23M
| $966K | ﹤0.01% |
292,863
-1,701
| -0.6% | -$5.07K |
|
2744
Vanguard Consumer Staples ETF
VDC
$8.03B
| $964K | ﹤0.01% |
5,200
-7,300
| -58% | -$1.41M |
|
2745
Avantis US Equity ETF
AVUS
$14.4B
| $963K | ﹤0.01% |
+14,800
| New | +$1.05M |
|
|
NRGD
2746
DELISTED
MicroSectors US Big Oil -3x Inverse Leveraged ETN
NRGD
| $963K | ﹤0.01% |
1,078
+559
| +108% | +$459K |
|
|
MFGP
2747
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
| $963K | ﹤0.01% |
285,800
+126,900
| +80% | +$588K |
|
2748
Kenon Holdings
KEN
$3.55B
| $960K | ﹤0.01% |
24,100
+19,200
| +392% | +$1.06M |
|
|
VBTX
2749
DELISTED
Veritex Holdings
VBTX
| $957K | ﹤0.01% |
+32,723
| New | +$1.09M |
|
2750
CNA Financial
CNA
$13.7B
| $956K | ﹤0.01% |
21,300
+15,300
| +255% | +$702K |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.